ZhuZhou QianJin Pharmaceutical Co Ltd Relative Valuation - ZhuZhou QianJin Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 10.78 CNY -0.55% Market Closed

Market Cap: ¥5.3B

	ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	CN
	CSW Industrials Inc NASDAQ:CSWI	US
	Shanghai Sanyou Medical Co Ltd SSE:688085	CN
	GGL Resources Corp. OTC:GGLXF	CA

Multiples-Based Value

The Multiples-Based Value of one ZhuZhou QianJin Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 10.78 CNY, ZhuZhou QianJin Pharmaceutical Co Ltd is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

ZhuZhou QianJin Pharmaceutical Co Ltd Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN		ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	5.3B CNY	1.5	21.2	15.7	15.7
US		Eli Lilly and Co NYSE:LLY	887.6B USD	13.6	43	29	31
US		Johnson & Johnson NYSE:JNJ	574.2B USD	6.1	21.4	14.9	18.3
UK		AstraZeneca PLC LSE:AZN	236.2B GBP	5.3	30.6	16.9	23.8
CH		Roche Holding AG SIX:ROG	248.4B CHF	4.1	19.6	11.6	13
US		Merck & Co Inc NYSE:MRK	300.5B USD	4.6	16.5	10.2	12.4
CH		Novartis AG SIX:NOVN	234.4B CHF	5.2	21	13	16.7
IE	E	Endo International PLC LSE:0Y5F	244.4B USD	105.4	-83.6	386.8	970
DK		Novo Nordisk A/S CSE:NOVO B	1.1T DKK	3.5	10.5	7.8	9.1
US		Pfizer Inc NYSE:PFE	153.1B USD	2.4	19.7	7.6	10.1
US		Bristol-Myers Squibb Co NYSE:BMY	118B USD	2.5	16.7	7.1	8.7

				Revenue Growth	P/S to Growth
CN		ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	Average P/S: 14 1.5	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	13.6	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.1	7%	0.9
UK		AstraZeneca PLC LSE:AZN	5.3	N/A	N/A
CH		Roche Holding AG SIX:ROG	4.1	4%	1
US		Merck & Co Inc NYSE:MRK	4.6	5%	0.9
CH		Novartis AG SIX:NOVN	5.2	5%	1
IE	E	Endo International PLC LSE:0Y5F	105.4	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.5	1%	3.5
US		Pfizer Inc NYSE:PFE	2.4	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
CN		ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	Average P/E: 22 21.2	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	43	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.4	7%	3.1
UK		AstraZeneca PLC LSE:AZN	30.6	26%	1.2
CH		Roche Holding AG SIX:ROG	19.6	14%	1.4
US		Merck & Co Inc NYSE:MRK	16.5	14%	1.2
CH		Novartis AG SIX:NOVN	21	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -83.6	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10.5	1%	10.5
US		Pfizer Inc NYSE:PFE	19.7	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	16.7	16%	1

				EBITDA Growth	EV/EBITDA to Growth
CN		ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	Average EV/EBITDA: 47.3 15.7	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	29	22%	1.3
US		Johnson & Johnson NYSE:JNJ	14.9	2%	7.4
UK		AstraZeneca PLC LSE:AZN	16.9	13%	1.3
CH		Roche Holding AG SIX:ROG	11.6	6%	1.9
US		Merck & Co Inc NYSE:MRK	10.2	3%	3.4
CH		Novartis AG SIX:NOVN	13	5%	2.6
IE	E	Endo International PLC LSE:0Y5F	386.8	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.8	1%	7.8
US		Pfizer Inc NYSE:PFE	7.6	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7.1	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
CN		ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	Average EV/EBIT: 102.6 15.7	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	31	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.3	6%	3
UK		AstraZeneca PLC LSE:AZN	23.8	21%	1.1
CH		Roche Holding AG SIX:ROG	13	6%	2.2
US		Merck & Co Inc NYSE:MRK	12.4	6%	2.1
CH		Novartis AG SIX:NOVN	16.7	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	970	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	9.1	2%	4.6
US		Pfizer Inc NYSE:PFE	10.1	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.7	-7%	N/A

ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples ZhuZhou QianJin Pharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479

Competitors Multiples
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors